Description
Eosinophil cationic protein (ECP) is one of the major mediators of eosinophils, involved in the development of atopic dermatitis, asthma, allergic rhinitis, and food allergy. Its serum concentration is measured to assess the activity of these diseases and to monitor their treatment.
Advantages of ImmunoCAP technology
The most accurate modern technology for laboratory diagnosis of allergic diseases.
The uniqueness of ImmunoCAP technology lies in its high informativeness and the ability to detect even very low concentrations of ECP in the blood.
The technology is based on immunofluorescence on a three-dimensional porous solid phase, which provides maximum sensitivity and specificity of the test.
The World Health Organization and the World Allergy Organization recognize ImmunoCAP technology as the "gold standard" of allergy diagnostics, as it has proven its effectiveness in independent studies.
Thus, determining ECP concentration using this method brings allergy diagnostics to a qualitatively new level.
Period of execution
Within 7 days. The specified time does not include the day of biomaterial collection
Biomaterial type